The ADHD probands were treated with either stimulant (MPH) or non-stimulant (atomoxetine/ATX) medications based on the age at presentation, presenting symptoms, and availability of the medicine, and the treatment efficacy was tested in the probands having different GRIK1 genotypes. Here, GRIK1 is linked to attention deficit-hyperactivity disorder.